Versant Capital Management’s Prothena Corp PRTA Stock Holding History

Versant Capital Management’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20K	Sell	2,044 -148	-7%	-$1.46K	﹤0.01%	1930
2026 Q1	$21.3K	Buy	2,192 +148	+7%	+$1.36K	﹤0.01%	1788
2025 Q4	$19.5K	Hold	2,044	–	–	﹤0.01%	1659
2025 Q3	$19.9K	Hold	2,044	–	–	﹤0.01%	1581
2025 Q2	$12.4K	Buy	2,044 +1,513	+285%	+$11.4K	﹤0.01%	1791
2025 Q1	$6.57K	Sell	531 -98	-16%	-$1.39K	﹤0.01%	1917
2024 Q4	$8.71K	Buy	629 +304	+94%	+$4.8K	﹤0.01%	1481
2024 Q3	$5.44K	Buy	325 +271	+502%	+$5.83K	﹤0.01%	1268
2024 Q2	$1.11K	Buy	+54	New	+$1.17K	﹤0.01%	1651
2023 Q3	–	Sell	-6	Closed	-$410	–	2029
2023 Q2	$410	Buy	+6	New	+$387	﹤0.01%	1875
2018 Q2	–	Sell	-12	Closed	–	–	1607
2018 Q1	$0	Hold	12	–	–	﹤0.01%	1617
2017 Q4	$0	Hold	12	–	–	﹤0.01%	1612
2017 Q3	$0	Hold	12	–	–	﹤0.01%	1539
2017 Q2	$0	Hold	12	–	–	﹤0.01%	1516
2017 Q1	$0	Hold	12	–	–	﹤0.01%	1513
2016 Q4	$0	Hold	12	–	–	﹤0.01%	1494
2016 Q3	$0	Hold	12	–	–	﹤0.01%	1460
2016 Q2	$0	Hold	12	–	–	﹤0.01%	1414
2016 Q1	$0	Hold	12	–	–	﹤0.01%	1426
2015 Q4	$0	Buy	+12	New	+$724	﹤0.01%	1409

Other funds holding PRTA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Versant Capital Management's PRTA Position: Q2 2026 in Review

Versant Capital Management reduced its Prothena Corp (PRTA) stake by 6.8% in Q2 2026, selling an estimated $1.46K and leaving 2,044 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Versant Capital Management first reported a position in PRTA in Q4 2015 and has held it in 20 quarters since. The position peaked at $21.3K in Q1 2026. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

Versant Capital Management held 2,044 shares of Prothena Corp worth $20K as of Q2 2026.
Versant Capital Management sold 148 Prothena Corp shares in Q2 2026, an estimated $1.46K.
Prothena Corp made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1930 holding.
Versant Capital Management first reported a position in Prothena Corp in Q4 2015 and has held it in 20 quarters since.
Versant Capital Management's Prothena Corp position peaked at $21.3K in Q1 2026.
187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.